After weeks of indicating that perhaps the Bird Flu hoax was going to be recycled again as a new “pandemic” to instill fear and continue the state of “emergency” the entire country has been under since 2020 that has resulted in $trillions given over to Big Pharma for their products, mainly the COVID-19 “vaccines,” it appears now that plans are in place to actually use the “monkeypox” as the new “pandemic” to further the goals of the Globalists to create new vaccines and control the population.
The World Health Organization just announced that they are “convening an emergency meeting on the alarming spread of monkeypox around the world.”
Just how bad is this new “outbreak” which now threatens the world in a similar way to how COVID threatened to wipe out humanity?
Cases of monkeypox in the UK doubled this week – to an “alarming” 20 cases. And it is now spreading to the U.S. at an alarming rate, as one person has reportedly now tested positive for it (determined by the PCR test apparently) in New York City.
It appears that worldwide this “alarming spread” of monkeypox is well below 100 cases at this point, which means it would probably not even break into the top 1000 list of current infectious diseases spreading around the globe.
So why the media hype and sudden attention by government health organizations like the WHO and the CDC?
The first clue that this is a new “plandemic” is to see how Big Pharma is setup to profit from it, because disease management is first and foremost a marketing opportunity, and to create to the proper fear factor, one has to advertise a “new” and “deadly” disease to start the funds flowing through emergency use authorizations.
And sure enough, that first criterion for identifying a “plandemic” has been met this week, as Whitney Webb reported:
“In recent days, concern over a global outbreak of monkeypox…two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.”
The second sign to look for, is if this “new outbreak” has already been predicted beforehand, and even simulated in an effort to predict how to “contain the outbreak,” much as COVID-19 was weeks before the first alleged cases even showed up, with the pandemic simulation called Event 201.
And thanks to some investigations by Polly St. George, there was indeed a simulation of a “monkeypox” pandemic simulated in March of 2021 hosted by the Nuclear Threat Initiative with the Munich Security Conference to “conduct a tabletop exercise on reducing high-consequence biological threats.”